Source: Annual Congress 2009 - Pleural and mediastinal diseases
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
L. Jones, S. Bolton, A. M. Seymour (Leeds, Dewsbury, Wakefield, United Kingdom). Audit of pain control in patients with mesothelioma. Eur Respir J 2009; 34: Suppl. 53, 4117

Member's Comments

No comment yet.

Related content which might interest you: A randomised trial of active symptom control (ASC) with or without chemotherapy (CT) in the treatment of patients with malignant pleural mesothelioma. First results of the Medical Research Council/British Thoracic Society MS01 trial Source: Annual Congress 2007 - Pleural malignancy Year: 2007 Evaluating the outcomes of patients with haemoptysis referred to two rapid-access lung cancer clinics in the UK Source: Virtual Congress 2020 – Management issues in thoracic oncology Year: 2020 Salvage treatment in patients with recurrent or resistant malignant pleura mesothelioma. A retrospective study from tertiary oncology department Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Audit of process of care of elderly patients with lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 432s Year: 2003 Audit of primary care referral guidelines for patients with suspected lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 63s Year: 2001 Impact of sarcopenia in long-term symptoms in patients with malignant pleural effusion. Source: Virtual Congress 2021 – Accurate diagnosis and prediction of malignant pleural disease Year: 2021 A Dutch web-survey on management of malignant pleural effusions Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011 Medical thoracoscopy for diagnosis of pleural effusion in cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 528s Year: 2004 What outcome after pleurodesis in malignant pleural effusion in lung cancer? Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015 A feasibility study of pulmonary rehabilitation at home in patients with lung cancer or malignant pleural mesothelioma treated by (radio-)chemotherapy Source: International Congress 2014 – Best abstracts in pulmonary rehabilitation and exercise training Year: 2014 Prognostic value of treatment outcomes patients with malignant pleural mesothelioma Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010 How to improve diagnosis and care for mesothelioma patients in Europe Source: International Congress 2019 – Rare lung diseases Year: 2019 The need for early MDT assessment of lung cancer patients presenting with pain Source: Eur Respir J 2003; 22: Suppl. 45, 432s Year: 2003 Outpatient management of malignant pleural effusion in patients unfit for pleurodesis Source: International Congress 2016 – Open problems in thoracic surgery Year: 2016 Influence of psychological distress on symptom burden of patients admitted by malignant pleural effusion Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside Year: 2020 LATE-BREAKING ABSTRACT: Impact of NSAIDs on success of chemical pleurodesis in malignant pleural effusion Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Time to diagnosis and time to therapy in patients with malignant pleural mesothelioma (MPM) compared to patients with lung cancer in Denmark 2007 to 2011. A quality assurance analysis Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012 An examination of the factors for successful pleurodesis against malignant pleural effusion (MPE) Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Are patients with malignant pleural effusions being referred appropriately for surgical intervention? Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology Year: 2008 Survival after intrapleural catheter (IPC) insertion for malignant pleural effusion (MPE): a retrospective audit of prognostic scoring tools in patients with MPE treated with an IPC in a district general hospital. Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020